Search

everythinglearnresearchcommunity

for

Search:↓

Telogen effluvium is the most common hair loss in women, often linked to low iron, while tight hairstyles and headscarves increase traction alopecia risk.

Female pattern hair loss is linked to genetics, family history, and lifestyle factors.

Childhood and adult height, and early immune-related hospitalizations increase testicular cancer risk, while baldness, larger families, and sports reduce it.

PCOS involves genetic and immune factors, especially T cells, affecting its development.

Finasteride may increase stroke risk in people with clotting tendencies.

Some blood-thinning medications can increase the risk of bleeding, and certain factors like genetics and other health conditions affect their safety and effectiveness.

Higher blood pressure and genetics increase alopecia risk.

Acne and hidradenitis suppurativa have different causes and risk factors, but both are driven by inflammation and may benefit from treatments targeting interleukin-1.

New research has found 14 genes linked to the risk of developing alopecia areata, improving understanding and treatment options.

Controlling cellular changes can enable safe rejuvenation without cancer risk.

Naive Bayes algorithm can help predict hair loss risk early.

Organ transplant recipients have a higher risk of skin cancer over time, atopic dermatitis skin shows unusual bacterial and fungal patterns, a new tool for measuring hidradenitis suppurativa severity was created, and gene expression changes in male baldness suggest new treatments.

Certain gene variations may increase the risk of alopecia, and platelet-rich plasma treatment can improve hair density in those with hair loss; a rare case of facial Becker's nevus was linked to uneven beard growth.

Obesity in children can worsen skin issues and increase infection risk.

Protein kinase C epsilon may increase skin cancer risk by affecting nearby cells.

Early sunburn treatment with certain inhibitors may reduce skin cancer risk.

High TNF-α levels may increase hair loss risk after PRP therapy.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

The link between anabolic agents and colorectal cancer risk is unclear.

Many COVID-19 patients have long-term symptoms, especially women, but certain medications may help reduce these symptoms.

Hyperandrogenism increases heart disease risk in premenopausal women, but this risk is linked to obesity in postmenopausal women.

Higher cholesterol levels increase aggressive prostate cancer risk.

Captive management practices affect hair loss and stress in rhesus monkeys, with differences between facilities.

An unhealthy lifestyle increases the risk of metabolic syndrome.

Age and diabetes are linked to larger trichilemmal cysts, while hypertension is linked to smaller ones.

People with Major Depressive Disorder have a higher chance of getting Alopecia Areata, and vice versa; antidepressants may lower this risk.

Copper may protect against alopecia areata, while certain inflammatory markers increase risk.

Biotin effectively treats hair loss, skin, and nail issues without overdose risk.

Alopecia areata causes sudden hair loss, has genetic links, and can be managed but not cured.

Collagen VII helps skin heal and stay strong, sirolimus may lower skin cancer risk in kidney transplant patients, high-molecular-mass hyaluronan helps naked mole rats resist cancer, dermal γδ T cells aid in hair growth in rodents, and overexpression of IL-33 in mouse skin causes itchiness, offering a model for studying allergic inflammation treatments.